LON:ARIX Arix Bioscience Share Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Arix Bioscience plc Please log in to your account or sign up in order to add this asset to your watchlist. GBX 112.25 0.00 (0.00%) (As of 06/24/2022 12:00 AM ET) Add Compare Share Today's Range 112.25▼ 112.7050-Day Range 111▼ 11952-Week Range 110▼ 182Volume3,880 shsAverage Volume155,209 shsMarket Capitalization£145.06 millionP/E RatioN/ADividend YieldN/APrice TargetGBX 256 ProfileAnalyst RatingsChartCompetitorsInsider TradesHeadlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive ARIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Arix Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address ARIX Stock Forecast (MarketRank)Overall MarketRank™1.64 out of 5 starsAnalyst Opinion: 3.3Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 - 3.3 Analyst's Opinion Consensus RatingArix Bioscience has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of GBX 256, Arix Bioscience has a forecasted upside of 128.1% from its current price of GBX 112.25.Amount of Analyst CoverageArix Bioscience has received no research coverage in the past 90 days. Previous Next 4.3 Community Rank Outperform VotesArix Bioscience has received 82 “outperform” votes. (Add your “outperform” vote.)Underperform VotesArix Bioscience has received 47 “underperform” votes. (Add your “underperform” vote.)Community SentimentArix Bioscience has received 63.57% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Arix Bioscience and other stocks. Vote “Outperform” if you believe ARIX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ARIX will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldArix Bioscience does not currently pay a dividend.Dividend GrowthArix Bioscience does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Arix Bioscience insiders have not sold or bought any company stock. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Arix Bioscience is -2.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Arix Bioscience is -2.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioArix Bioscience has a P/B Ratio of 0.55. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Arix Bioscience (LON:ARIX)Arix Bioscience plc is a venture capital firm specializing in all stages of growth, seed stage, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity. The firm seeks to invest in biotech companies, novel therapeutics, innovative technologies, medical innovation comprising healthcare and life sciences. It seeks to invest globally. The firm employs an evergreen approach to funding. It primarily makes investments from its own balance sheet. The firm prefers to take board seat. The firm exit when the optimum value has been reached. Arix Bioscience plc is formerly known as Perceptive Bioscience Investments Limited. Arix Bioscience plc was founded in 2015 and is based in London, United Kingdom.Read More ARIX Stock News HeadlinesJune 9, 2022 | uk.finance.yahoo.comUnaudited NAV for May 2022June 7, 2022 | markets.businessinsider.comResult of Annual General Meeting 2022June 7, 2022 | finanznachrichten.deArix Bioscience PLC: Result of Annual General Meeting 2022May 30, 2022 | finance.yahoo.comWhat Kind Of Investors Own Most Of Arix Bioscience plc (LON:ARIX)?May 17, 2022 | uk.finance.yahoo.comHow do brokers rate Arix Bioscience?May 11, 2022 | uk.finance.yahoo.comUnaudited NAV for AprilApril 29, 2022 | markets.businessinsider.comUnaudited NAV and Notice of Financial ResultsApril 29, 2022 | finanznachrichten.deArix Bioscience PLC: Unaudited NAV and Notice of Financial ResultsApril 28, 2022 | proactiveinvestors.com.auGreencare announces board changes, with chief executive stepping downMarch 22, 2022 | proactiveinvestors.comDirector changes at ReNeuron’s boardMarch 22, 2022 | proactiveinvestors.com.auReNeuron unveils board reshuffle as part of business refocusMarch 14, 2022 | finanznachrichten.deArix Bioscience PLC: Corporate update from portfolio company Harpoon TherapeuticsJanuary 13, 2022 | finanznachrichten.deArix Bioscience PLC: Notification of Major Share HoldingSee More Headlines Industry, Sector and Symbol Stock ExchangeLON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:ARIX CUSIPN/A CIKN/A Webarixbioscience.com Phone+44-20-72901050FaxN/AEmployees12Year FoundedN/ACompany Calendar Today6/26/2022Next Earnings (Estimated)8/10/2022Price Target and Rating Average Stock Price ForecastGBX 256 High Stock Price ForecastGBX 256 Low Stock Price ForecastGBX 256 Forecasted Upside/Downside+128.1%Consensus RatingModerate Buy Rating Score (0-4)2.66666666666667 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.05 Current Ratio85.04 Quick Ratio84.95 Sales & Book Value Annual Sales£-53.58 million Price / Sales-2.71 Cash FlowGBX 108.15 per share Price / Cash Flow1.04 Book ValueGBX 205.80 per share Price / Book0.55Miscellaneous Outstanding Shares129,230,000Free FloatN/AMarket Cap£145.06 million OptionableNot Optionable BetaN/A Arix Bioscience Frequently Asked Questions Should I buy or sell Arix Bioscience stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Arix Bioscience in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" Arix Bioscience stock. View analyst ratings for Arix Bioscience or view top-rated stocks. What is Arix Bioscience's stock price forecast for 2022? 3 analysts have issued 12-month price targets for Arix Bioscience's shares. Their ARIX stock forecasts range from GBX 256 to GBX 256. On average, they anticipate Arix Bioscience's share price to reach GBX 256 in the next twelve months. This suggests a possible upside of 128.1% from the stock's current price. View analysts' price targets for Arix Bioscience or view top-rated stocks among Wall Street analysts. How has Arix Bioscience's stock performed in 2022? Arix Bioscience's stock was trading at GBX 121 at the beginning of the year. Since then, ARIX shares have decreased by 7.2% and is now trading at GBX 112.25. View the best growth stocks for 2022 here. When is Arix Bioscience's next earnings date? Arix Bioscience is scheduled to release its next quarterly earnings announcement on Wednesday, August 10th 2022. View our earnings forecast for Arix Bioscience. Who are Arix Bioscience's key executives? Arix Bioscience's management team includes the following people: Mr. Robert Lyne, CEO, Gen. Counsel, Company Sec. & DirectorMs. Nikki Edgar, Head of Fin.Mr. Mark Chin M.B.A., M.S., Managing Director (Age 40) Who are some of Arix Bioscience's key competitors? Some companies that are related to Arix Bioscience include Ergomed (ERGO), Silence Therapeutics (SLN), PureTech Health (PRTC), Oxford Biomedica (OXB), Pfenex (PFNX), Dyne Therapeutics (DYN), ProMetic Life Sciences (PLI), Horizon Discovery Group plc (HZD.L) (HZD), Precigen (PGEN), Theratechnologies (TH), Inventiva (IVA), VIVO Cannabis (ABCN), Emblem (EMC), Verona Pharma plc (VRP.L) (VRP) and Fennec Pharmaceuticals (FRX). View all of ARIX's competitors. What is Arix Bioscience's stock symbol? Arix Bioscience trades on the London Stock Exchange (LON) under the ticker symbol "ARIX." How do I buy shares of Arix Bioscience? Shares of ARIX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Arix Bioscience's stock price today? One share of ARIX stock can currently be purchased for approximately GBX 112.25. How much money does Arix Bioscience make? Arix Bioscience (LON:ARIX) has a market capitalization of £145.06 million and generates £-53.58 million in revenue each year. How many employees does Arix Bioscience have? Arix Bioscience employs 12 workers across the globe. How can I contact Arix Bioscience? Arix Bioscience's mailing address is 20 Berkeley Square, LONDON, W1J 6EQ, United Kingdom. The official website for Arix Bioscience is arixbioscience.com. The company can be reached via phone at +44-20-72901050. This page (LON:ARIX) was last updated on 6/26/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
